Application Sponsors
| ANDA 209872 | STI PHARMA LLC |  | 
Marketing Status
| Prescription | 001 | 
| Prescription | 002 | 
Application Products
| 001 | CAPSULE;ORAL | 25MG | 0 | CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | 
| 002 | CAPSULE;ORAL | 50MG | 0 | CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | 
FDA Submissions
| UNKNOWN;  | ORIG | 1 | AP | 2018-05-07 | STANDARD  | 
Submissions Property Types
TE Codes
| 001 | Prescription | AB | 
| 002 | Prescription | AB | 
CDER Filings
STI PHARMA LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 209872
            [companyName] => STI PHARMA LLC
            [docInserts] => ["",""]
            [products] => [{"drugName":"CYCLOPHOSPHAMIDE","activeIngredients":"CYCLOPHOSPHAMIDE","strength":"25MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"CYCLOPHOSPHAMIDE","activeIngredients":"CYCLOPHOSPHAMIDE","strength":"50MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"05\/07\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2018-05-07
        )
)